US Patent Issued to VISTERRA on June 24 for "Humanized antibody molecules to CD138 and uses thereof" (Massachusetts Inventors)

ALEXANDRIA, Va., June 25 -- United States Patent no. 12,338,291, issued on June 24, was assigned to VISTERRA INC. (Waltham, Mass.).

"Humanized antibody molecules to CD138 and uses thereof" was invented by Bharat Chaganty (Concord, Mass.), Boopathy Ramakrishnan (Braintree, Mass.), Hedy Adari-Hall (Sudbury, Mass.), Karthik Viswanathan (Acton, Mass.), James R. Myette (Waltham, Mass.), Zachary Shriver (Winchester, Mass.) and Andrew M. Wollacott (Milton, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Humanized antibody molecules that specifically bind to CD138 are disclosed. The humanized antibody molecules can be used to treat, prevent, and/or diagnose disorders, such as multiple myeloma."

The patent was ...